Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
There is an upward development for Enwave Corporation compared to yesterday, with an increase of €0.003 (1.740%).
Pros and Cons of Enwave Corporation in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | 1.740% | -6.915% | -12.060% | 23.239% | -25.847% | 1.863% | -81.020% |
| Aurinia Pharmaceuticals Inc. | 0.740% | 1.377% | 4.466% | 64.888% | -7.090% | 47.670% | 8.637% |
| Spectral Medical Inc | -2.440% | -1.235% | 0.629% | 85.185% | 0.629% | 284.615% | 146.914% |
| Xenon Pharmaceuticals Inc. | -2.800% | 34.254% | 38.857% | 50.000% | 27.895% | 51.875% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth